|
1
|
Chollet F, Cramer SC, Stinear C, et al:
Pharmacological therapies in post stroke recovery: recommendations
for future clinical trials. J Neurol. (Epub ahead of print).
2013.PubMed/NCBI
|
|
2
|
Candelario-Jalil E: Injury and repair
mechanisms in ischemic stroke: considerations for the development
of novel neurotherapeutics. Curr Opin Investig Drugs. 10:644–654.
2009.PubMed/NCBI
|
|
3
|
Lo EH, Dalkara T and Moskowitz MA:
Mechanisms, challenges and opportunities in stroke. Nat Rev
Neurosci. 4:399–415. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mustacich D and Powis G: Thioredoxin
reductase. Biochem J. 346(Pt 1): 1–8. 2000. View Article : Google Scholar
|
|
5
|
Kishimoto K, Li RC, Zhang J, et al:
Cytosolic phospholipase A2 alpha amplifies early cyclooxygenase-2
expression, oxidative stress and MAP kinase phosphorylation after
cerebral ischemia in mice. J Neuroinflammation. 7:422010.
|
|
6
|
Stoyanova II and Lazarov NE: Localization
of nitric oxide synthase in rat trigeminal primary afferent neurons
using NADPH-diaphorase histochemistry. J Mol Histol. 36:187–193.
2005. View Article : Google Scholar
|
|
7
|
Bredt DS and Snyder SH: Nitric oxide
mediates glutamate-linked enhancement of cGMP levels in the
cerebellum. Proc Natl Acad Sci USA. 86:9030–9033. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kawase M, Kinouchi H, Kato I, et al:
Inducible nitric oxide synthase following hypoxia in rat cultured
glial cells. Brain Res. 738:319–322. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hirota K, Nakamura H, Masutani H and Yodoi
J: Thioredoxin superfamily and thioredoxin-inducing agents. Ann N Y
Acad Sci. 957:189–199. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Berk BC: Novel approaches to treat
oxidative stress and cardiovascular diseases. Trans Am Clin
Climatol Assoc. 118:209–214. 2007.PubMed/NCBI
|
|
11
|
Billiet L, Furman C, Cuaz-Pérolin C, et
al: Thioredoxin-1 and its natural inhibitor, vitamin D3
up-regulated protein 1, are differentially regulated by PPARalpha
in human macrophages. J Mol Biol. 384:564–576. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Watson HW, Yang X, Choi YE, Jones DP and
Kehrer JP: Thioredoxin and its role in toxicology. Toxicol Sci.
78:3–14. 2004. View Article : Google Scholar
|
|
13
|
Xu W, Yang J and Wu LM: Cardioprotective
effects of tanshinone IIA on myocardial ischemia injury in rats.
Pharmazie. 64:332–336. 2009.PubMed/NCBI
|
|
14
|
Lam BY, Lo AC, Sun X, Luo HW, Chung SK and
Sucher NJ: Neuroprotective effects of tanshinones in transient
focal cerebral ischemia in mice. Phytomedicine. 10:286–291. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dong K, Xu W, Yang J, Qiao H and Wu L:
Neuroprotective effects of Tanshinone IIA on permanent focal
cerebral ischemia in mice. Phytother Res. 23:608–613. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Adams JD, Wang R, Yang J and Lien EJ:
Preclinical and clinical examinations of Salvia miltiorrhiza
and its tanshinones in ischemic conditions. Chin Med. 1:32006.
View Article : Google Scholar
|
|
17
|
Liu LL, Zhang XL, Wang L, et al: The
neuroprotective effects of Tanshinone IIA are associated with
induced nuclear translocation of TORC1 and upregulated expression
of TORC1, pCREB and BDNF in the acute stage of ischemic stroke.
Brain Res Bull. 82:228–233. 2010. View Article : Google Scholar
|
|
18
|
Chen X, Zhou ZW, Xue CC, Li XX and Zhou
SF: Role of P-glycoprotein in restricting the brain penetration of
tanshinone IIA, a major active constituent from the root of
Salvia miltiorrhiza Bunge, across the blood-brain barrier.
Xenobiotica. 37:635–678. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
National Research Council. Guide for the
care and use of laboratory animals. 8th edition. The National
Academies Press; Washington, DC: pp. 1–246. 2001
|
|
20
|
Engel O, Kolodziej S, Dirnagl U and Prinz
V: Modeling stroke in mice - middle cerebral artery occlusion with
the filament model. J Vis Exp. 47:e24232011.PubMed/NCBI
|
|
21
|
Longa EZ, Weinstein PR, Carlson S and
Cummins R: Reversible middle cerebral artery occlusion without
craniectomy in rats. Stroke. 20:84–91. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hoffman GE, Merchenthaler I and Zup SL:
Neuroprotection by ovarian hormones in animal models of
neurological disease. Endocrine. 29:217–231. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang LN, Zhang XJ, Liu LL, et al:
Tanshinone IIA down-regulates HMGB1, RAGE, TLR4, NF-kappaB
expression, ameliorates BBB permeability and endothelial cell
function, and protects rat brains against focal ischemia. Brain
Res. 1321:143–151. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tang C, Xue HL, Bai CL, Fu R and Wu AH:
The effects of Tanshinone IIA on blood-brain barrier and brain
edema after transient middle cerebral artery occlusion in rats.
Phytomedicine. 17:1145–1149. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen D, Tang J, Khatibi NH, et al:
Treatment with Z-ligustilide, a component of Angelica
sinensis, reduces brain injury after a subarachnoid hemorrhage
in rats. J Pharmacol Exp Ther. 337:663–672. 2011.PubMed/NCBI
|
|
26
|
Cavallucci V and D’Amelio M: Matter of
life and death: the pharmacological approaches targeting apoposis
in brain diseases. Curr Pharm Des. 17:215–229. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Nizamutdinova IT, Jin YC, Kim JS, et al:
Paeonol and paeoniflorin, the main active principles of Paeonia
albiflora, protect the heart from myocardial
ischemia/reperfusion injury in rats. Planta Med. 74:14–18.
2008.PubMed/NCBI
|
|
28
|
Liu Y, Wang L, Li X, Lv C, Feng D and Luo
Z: Tanshinone IIA improves impaired nerve functions in experimental
diabetic rats. Biochem Biophys Res Commun. 399:49–54. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang WJ, Feng J, Zhou R, et al:
Tanshinone IIA protects the human blood-brain barrier model from
leukocyte-associated hypoxia-reoxygenation injury. Eur J Pharmacol.
648:146–152. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Anctil M, Poulain I and Pelletier C:
Nitric oxide modulates peristaltic muscle activity associated with
fluid circulation in the sea pansy Renilla koellikeri. J Exp
Biol. 208:2005–2017. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Das KC: Thioredoxin system in premature
and newborn biology. Antioxid Redox Signal. 6:177–184. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Nalvarte I, Damdimopoulos AE and Spyrou G:
Human mitochondrial thioredoxin reductase reduces cytochrome
c and confers resistance to complex III inhibition. Free Rad
Biol Med. 36:1270–1278. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liu R1, Gao M, Yang ZH, et al: Pinocembrin
protects rat brain against oxidation and apoptosis induced by
ischemia-reperfusion both in vivo and in vitro. Brain Res.
1216:104–15. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Dohare P, Varma S and Ray M: Curcuma oil
modulates the nitric oxide system response to cerebral
ischemia/reperfusion injury. Nitric Oxide. 19:1–11. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Blomgren K and Hagberg H: Free radicals,
mitochondria, and hypoxia-ischemia in the developing brain. Free
Radic Biol Med. 40:388–97. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Han JD: The investigation of
nerveprotective effect and mechanism of TongLuoHuaTan capsule and
its active ingredient on cerebral ischemia reperfusion injury.
Beijing University of Chinese Medicine; Doctoral dissertation.
2012
|
